Africa

DETAILED DESCRIPTION OF DALLAS HOPSITAL'S LEARNING ON THE FLY TO COPE WITH ITS FIRST EBOLA PATIENT.

THE WASHINGTON POST           Oct. 15, 2014
By Amy Ellis Nutt, Abby Phillip and Joel Achenbach

DALLAS — The hospital that treated Ebola victim Thomas Eric Duncan had to learn on the fly how to control the deadly virus, adding new layers of protective gearfor workers in what became a losing battle to keep the contagion from spreading, a top official with the Centers for Disease Control and Prevention said Tuesday.

“They kept adding more protective equipment as the patient [Duncan] deteriorated. They had masks first, then face shields, then the positive-pressure respirator. They added a second pair of gloves,” said Pierre Rollin, a CDC epidemiologist.

ASSOCIATED PRESS                    Oct. 15, 2010

DALLAS — A second health care worker at a Dallas hospital who provided care for the first Ebola patient diagnosed in the U.S. has tested positive for the disease, the Texas Department of State Health Services said Wednesday.

The department said in a statement that the worker reported a fever Tuesday and was immediately isolated at Texas Health Presbyterian Hospital in Dallas. Health officials said the worker was among those who took care of Thomas Eric Duncan, who was diagnosed with Ebola after coming to the U.S. from Liberia. Duncan died Oct. 8.

The department said a preliminary Ebola test was conducted late Tuesday at a state public health laboratory in Austin, Texas, and came back positive during the night. Confirmatory testing was being conducted at the federal Centers for Disease Control and Prevention in Atlanta.

Read full story

http://www.bostonherald.com/news_opinion/national/southwest/2014/10/texas_dept_2nd_health_care_worker_tests_positive_for_ebola

FIERCE BOIOTECH RESEARCH                       Oct. 14, 2014
By Emily Mullin

Before the current Ebola outbreak, the virus had only appeared in Africa in fits and starts since its discovery in 1976, receding back into the jungle almost as quickly as it arrived. This relative rarity and the swiftness with which the disease kills its victims has, up until now, made Ebola an unattractive--not to mention daunting--prospect for drug developers. As a result, no approved drugs or vaccines against Ebola exist.

...the current situation in West Africa... has prompted the World Health Organization to call on international government agencies and the pharmaceutical industry to work together to speed up the development of promising therapies for experimental use for those most at risk of contracting the disease, which causes severe hemorrhagic fever.

Now, a handful of players are racing to get a treatment or vaccine to patients as quickly as possible, even though these drugs remain largely untested in humans.... 

Here is a list of organizations that are in the global spotlight right now with their investigational Ebola program

See full story and list

NBC NEWS                                                            OCT. 14, 2014

Facebook founder Mark Zuckerberg and his wife announced Tuesday they are donating $25 million to the U.S. Centers for Disease Control foundation to fight the Ebola crisis that has killed more than 4,440 people in west Africa.

"We need to get Ebola under control in the near term so that it doesn't spread further and become a long term global health crisis that we end up fighting for decades at large scale, like HIV or polio," Zuckerberg, who is worth $32 billion, said in a Facebook post. "We believe our grant is the quickest way to empower the CDC and the experts in this field to prevent this outcome."

The health agency has hundreds of staffers working on Ebola and has sent more than 100 experts to the virus zone — Liberia, Guinea, Sierra Leone and Nigeria. The CDC foundation collects funds for supplies, such as personal protective equipment, ready-to-eat meals, generators, vehicles and motorcycles, and thermal scanners to detect fever.

See full story